Manufactured to high-purity specifications, Tirzepatide is supplied as a lyophilized peptide to ensure enhanced stability, consistency, and long-term storage under appropriate laboratory conditions. Its molecular structure is optimized to support controlled research involving metabolic signaling, receptor interactions, and peptide innovation.
Tirzepatide is a synthetic peptide engineered to act as a dual receptor agonist, targeting both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) pathways. Due to its dual-pathway activity, Tirzepatide is of significant interest in advanced metabolic, endocrine, and peptide-based research.
Reviews
There are no reviews yet.